You just read:

Panacea Pharmaceuticals Completes Enrollment in Phase 1 Study of First-in-Class Cancer Vaccine Therapy in Patients with Persistent Prostate Cancer

News provided by

Panacea Pharmaceuticals, Inc.

Feb 01, 2018, 07:45 EST